GlassScriptPhysician profile
Carla Phipps
NPI 1396708855
$1,790.62
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $846 · 2021: $327 · 2022: $37.90.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $791.53 | 2019-2022 | |
| Amgen INC. | $163.96 | 2019-2020 | |
| Novo Nordisk INC | $136.85 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.58 | 2019-2020 | |
| Lilly USA, LLC | $85.60 | 2019-2020 | |
| Astellas Pharma US INC | $70.32 | 2019 | |
| Abbvie INC. | $52.69 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $51.89 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.91 | 2019-2020 | |
| Abbott Laboratories | $47.07 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $30.64 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $28.03 | 2020 | |
| Glaxosmithkline, LLC. | $27.05 | 2019-2020 | |
| Pfizer INC. | $24.57 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $24.09 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $23.82 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.75 | 2020 | |
| Amarin Pharma, INC. | $16.88 | 2020 | |
| Sage Therapeutics, LLC | $14.72 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.36 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Phipps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.